Company Filing History:
5 out of 28 
1 out of 291 
1 out of 21 
Years Active: 2013-2020
Title: Innovations of Steven James Kattman
Introduction
Steven James Kattman is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of cardiovascular research, holding a total of 7 patents. His work primarily focuses on methods and compositions for generating epicardium cells and cardiomyocytes from human pluripotent stem cells.
Latest Patents
One of Kattman's latest patents involves methods and products for obtaining cardiovascular lineage cells from human pluripotent stem cells (hPSCs). This innovative method includes several steps, such as contacting BMP component primed hPSCs with a cardiovascular mesoderm programming cocktail. This cocktail is designed to induce the hPSCs to differentiate into a cardiovascular mesoderm cell population. The process continues with the specification of a cardiovascular progenitor cell population and culminates in the production of cardiomyocyte lineage cells expressing cardiac troponin T and epicardial lineage cells expressing WT1. Another notable patent focuses on the production of cardiomyocytes from the differentiation of pluripotent stem cells, utilizing large volume suspension culture in the presence of ROCK inhibitors.
Career Highlights
Kattman has worked with notable organizations such as Cellular Dynamics International, Inc. and the University Health Network. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Throughout his career, Kattman has collaborated with esteemed colleagues, including Wen Bo Wang and Peter Fuhrken. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Steven James Kattman is a distinguished inventor whose work in cardiovascular research has led to significant advancements in the field. His innovative methods for generating cardiovascular lineage cells and cardiomyocytes from pluripotent stem cells are paving the way for future developments in regenerative medicine.